October 3-5, 2011 - Register Now! 2011 World Stem Cell Summit, The Pasadena Convention Center, Pasadena, CA.,

West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012

Co-Organizers of Largest Interdisciplinary Stem Cell Meeting Include: Genetics Policy Institute; Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine; and Diabetes Research Institute

West Palm Beach – Genetics Policy Institute (GPI) announced today that the 8th Annual World Stem Cell Summit is scheduled for Dec. 3–5, 2012 at the Palm Beach County Convention Center in West Palm Beach, Florida.

Genetics Policy Institute, Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine and the Diabetes Research Institute (DRI) have united to organize the world’s largest and most comprehensive multi-track interdisciplinary stem cell conference, featuring more than 170 renowned international speakers and 50 hours of in-depth programming in science, business and society tracks.

The Summit will feature prominent scientists, clinicians, industry leaders, regulators, policy-makers, advocates, philanthropists, economic development officers and experts in law and ethics, who will discuss the latest scientific discoveries, business models, translational issues, legal and regulatory solutions and best practices. The event is expected to attract 1,500 attendees from 25 nations, 70 exhibitors and more than 200 endorsing organizations and media partners.

2011 World Stem Cell Summit Program Highlights

2011 Summit

The 2011 World Stem Cell Summit took place in Pasadena, California on October 3-5, 2011 at the Pasadena Convention Center. The Summit is the largest interdisciplinary multi-track stem cell conference, featuring more than 170 expert speakers and 50 hours of in-depth science, business and society presentations.

The 2011 Summit was produced by the nonprofit Genetics Policy Institute (GPI) and co-organized with the California Institute for Regenerative Medicine (CIRM), City of Hope, Cedars-Sinai Regenerative Medicine Institute, Caltech, Keck School of Medicine at USC, Children’s Hospital Los Angeles and the Consulate General of Canada in Los Angeles.

With nearly 1,400 attendees, from 25 countries and more than 235 total sponsors, supporting organizations and media partners, the 2011 World Stem Cell Summit once again united the diverse regenerative community with the aim of accelerating the cutting edge research into effective treatments and cures.

Read the Full Recap | Watch the Webcast | 2011 World Stem Cell Report

About the Summit

Watch the Summit Webcast: 

Featured Speakers & Presenters

science: Chris Mason
Chris Mason
Read Bio >
Business: Yoon-Sun Yang
Yoon-Sun Yang
Read Bio >
science: Lawrence Goldstein
Lawrence Goldstein
Read Bio >
science: Rudolf Jaenisch
Rudolf Jaenisch
Read Bio >
Policy: Jeanne Loring
Jeanne Loring
Read Bio >
science: Norio Nakatsuji
Norio Nakatsuji
Read Bio >

The World Stem Cell Summit, produced by the Genetics Policy Institute (GPI), is the largest interdisciplinary, networking meeting of stem cell stakeholders, uniting the diverse regenerative medicine community. With the overarching purpose of fostering biomedical research, funding and investments targeting cures, the Summit is the single conference charting the future of this burgeoning field.

The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell puzzle fit together. The agenda features more than 150 speakers and 50 hours of in-depth presentations. Supported by 200 sponsors, exhibitors, endorsing organizations and media partners, the Summit is a three-day showcase of innovation, insight and inspiration.

The Summit’s industry track, standing alone, is the largest stem cell business conference in North America with top leaders from cell therapy, biotechnology, tool, devices and pharma in attendance on a program covering in depth the issues pertinent to translating basic research into cures, including discussions on regulatory pathways, cell standardization, reimbursements, financing, venture capital and economic development.


Awards Dinner

Tuesday Evening, October 4, 2011 – Pasadena Convention Center

The Genetics Policy Institute’s Stem Cell Action Awards were presented at the annual World Stem Cell Summit, which is often referred to as the ‘conference of hope.’ The awards recognize the dedicated individuals and organizations that positively impact the cause of stem cell research. GPI honored the stem cell community’s top innovators, leaders, and champions at the 2011 Stem Cell Action Awards Dinner. GPI recognized the organizations and individuals who have had the most positive impact on the stem cell community. The 2011 Stem Cell Action Award Honorees Included: Sherry Lansing (Leadership Award); Research!America (National Advocacy Award); Let's Talk Science (Education Award); University of Minnesota Stem Cell Institute (Public Advocacy Award) and Grant Albrecht (Inspiration Award). Learn more >

Summit Agenda

The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell puzzle fit together. The agenda features more than 150 speakers and 50 hours of in-depth presentations.
View Full Agenda >
Gil Van Bokkelen

Keynote Address:
Gil Van Bokkelen

Dr. Van Bokkelen co-founded Athersys in October 1995 and has served as CEO and Chairman since August 2000. Dr. Van Bokkelen is  Chairman of the Alliance for Regenerative Medicine, a Washington D.C. based consortium of companies, patient advocacy groups, disease foundations, and clinical and research institutions that are committed to the advancement of the field of regenerative medicine. He is also the Chairman of the Board of Governors for the National Center for Regenerative Medicine, and serves on a number of other boards, including the Biotechnology Industry Organization's ECS board of directors, the McGowan Institute for Regenerative Medicine and the Regenerative Medicine Foundation. He received his Ph.D. in Genetics from Stanford University, his B.A. in Economics from the University of California at Berkeley, and his B.A. in Molecular Biology from the University of California at Berkeley.

Andrew S. Grove - Keynote Speaker

Keynote Address:
Andrew S. Grove

Translational Medicine: Key to Progress or Bridge to Nowhere?

Andrew S. Grove is Senior Advisor to Intel Corporation. Previously Grove was Chairman of the Board of Intel Corporation from May 1997 to May 2005. From 1987 to 1998 he served as the company's CEO and from 1979 to 1997 he served as President. Prior to participating in the founding of Intel in 1968 with Robert Noyce and Gordon Moore, he worked as the Assistant Director of Research and Development for Fairchild Semiconductor. He has served as Patient Advocate at UCSF and was National Chair of the Campaign for UCSF. He was a member of the board for the Prostate Cancer Foundation. Dr. Grove is an advisor to the Michael J. Fox Foundation. He heads the Grove Foundation, a private philanthropic organization and focuses on supporting research on Parkinson's Disease.

View Full Agenda >

Who Attends

2010 World Stem Cell Summit Audience

Representatives from research, industry, ethics, law, government, economic development, finance, insurance, foundations, societies, patient advocates and media all attend the Summit. It is an event that unites the global stem cell science and regenerative medicine communities, fostering insight, collaborations, commerce and an overall more favorable environment to accelerate progress.

“The World Stem Cell Summit is a meeting of the stem cell minds, bringing Policy, science, industry, advocates and clinicians together in a unique and powerful forum. The Summit is of great value to researchers by providing a context for stem cell science that is not found at other meetings. By uniting the key stakeholder groups, the Summit grounds research direction with an understanding of the strategies that will be most beneficial for developing stem cell-based therapeutics.”

Sally Temple, Ph.D. Scientific Director
Neural Stem Cell Institute 

Read quotes from other past particpants

2011 World Stem Cell Report

More than 26 articles and 176 pages of previously unpublished insight into the forefront of regenerative medicine

The editors of the 2011 World Stem Cell Report invited more than 26 experts to share their views on regenerative medicine strategies in the regions of North and South America, Europe and the Asia Pacific region, where stem cell research is on the forefront the biomedical research and commercialization agenda. The report serves as a reference and guide to this diverse universe of organizations and networks that influence the success of our field.

The theme of the 2011 World Stem Cell Report is “Translational Regenerative Medicine: from Bench to Bedside.” The Report provides a worldwide perspective of the issues facing the stem cell community that influence how the field of stem cells and regenerative medicine develops. This edition includes discussions of science, international perspectives, commercialization, policy, law, ethics and advocacy.

View Table of Contents | Order Print Edition >

World Stem Cell Report 2011

Speakers & Program Participants

The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell puzzle fit together. The agenda features more than 150 speakers and 50 hours of in-depth presentations.  View All Speakers>

Featured Keynote Speakers

Rudolf Jaenisch Chris Mason Alan Trounson Arnold Kriegstein
Rudolf Jaenisch
MD
Member
Whitehead Institute
Professor of Biology, MIT
Cambridge, Massachusetts
Read Bio >
Chris Mason
MBBS, PhD, FRCS
Professor, Regenerative Medicine Bioprocessing
Advanced Centre for Biochemical Engineering
University College London
London, United Kingdom
Read Bio >
Alan Trounson
PhD
President
California Institute of Regenerative Medicine
San Francisco, California
Read Bio >
Arnold Kriegstein
MD, PhD
Director
Ely and Edythe Broad Center of Regeneration Medicine and Stem Cell
San Francisco, California
Read Bio >